Literature DB >> 11511703

Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study.

K Meguro1, C LeMestric, B Landeau, B Desgranges, F Eustache, J C Baron.   

Abstract

OBJECTIVES: Hippocampal atrophy and hypometabolism in the posterior association neocortex are two well known features of Alzheimer's disease. A correlation between these two features was reported twice previously, suggesting intriguing relations. This question has been reassessed, this time controlling for severity of dementia as well as assessing each side of the brain separately and using a voxel based image analysis in addition to the previously employed regions of interest (ROIs). PATIENTS AND METHODS: Eleven patients were studied with probable Alzheimer's disease and mild to moderate dementia in whom both volume MRI and PET assessed cerebral glucose consumption (CMRGlc) were available. Hypothesis driven correlations between hippocampal width (an index of atrophy) and CMRGlc were performed for two posterior association regions, the superior temporal and the inferior parietal (angular gyrus) cortices, using ROIs set separately for each hemisphere. To confirm significant correlations from the ROIs approach, if any, and to assess their specificity for the posterior association neocortex, CMRGlc image voxel based analysis of correlations with hippocampal width was then carried out.
RESULTS: There was a significant correlation, in the positive-neurobiologically expected-direction, between right hippocampal width and right angular gyrus metabolism (p< 0.01, Spearman), which remained significant with Kendall partial correlation controlling for dementia severity (estimated by mini mental state scores). Statistical non-parametric mapping (SnPM) confirmed this correlation (p< 0.025), and showed a single additional correlation in the right middle temporal gyrus (p< 0.005), which is also part of the posterior association cortex.
CONCLUSION: The findings with both ROIs and voxel based mapping replicate earlier reports of a relation between hippocampal atrophy and ipsilateral association cortex hypometabolism in Alzheimer's disease, and for the first time document that this relation is both region specific and independent of the dementing process itself. Why the correlation was significant only for the right hemisphere is unclear but may be related to the limited sample. Hippocampal-neocortical disconnection due to early and severe medial temporal lobe pathology may at least partly explain the posterior association cortex hypometabolism found in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511703      PMCID: PMC1737577          DOI: 10.1136/jnnp.71.3.315

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  37 in total

1.  Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease.

Authors:  K Meguro; X Blaizot; Y Kondoh; C Le Mestric; J C Baron; C Chavoix
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

2.  Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories.

Authors:  J C Pruessner; L M Li; W Serles; M Pruessner; D L Collins; N Kabani; S Lupien; A C Evans
Journal:  Cereb Cortex       Date:  2000-04       Impact factor: 5.357

3.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 4.  Hippocampal-neocortical interaction: a hierarchy of associativity.

Authors:  P Lavenex; D G Amaral
Journal:  Hippocampus       Date:  2000       Impact factor: 3.899

5.  Mapping biochemistry to metabolism: FDG-PET and amyloid burden in Alzheimer's disease.

Authors:  M S Mega; T Chu; J C Mazziotta; K H Trivedi; P M Thompson; A Shah; G Cole; S A Frautschy; A W Toga
Journal:  Neuroreport       Date:  1999-09-29       Impact factor: 1.837

6.  Pathological and positron emission tomographic correlations in Alzheimer's disease.

Authors:  R P Friedland; A Brun; T F Budinger
Journal:  Lancet       Date:  1985-01-26       Impact factor: 79.321

7.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.

Authors:  M E Phelps; S C Huang; E J Hoffman; C Selin; L Sokoloff; D E Kuhl
Journal:  Ann Neurol       Date:  1979-11       Impact factor: 10.422

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.

Authors:  R P Friedland; T F Budinger; E Ganz; Y Yano; C A Mathis; B Koss; B A Ober; R H Huesman; S E Derenzo
Journal:  J Comput Assist Tomogr       Date:  1983-08       Impact factor: 1.826

10.  Alzheimer's disease: focal cortical changes shown by positron emission tomography.

Authors:  N L Foster; T N Chase; P Fedio; N J Patronas; R A Brooks; G Di Chiro
Journal:  Neurology       Date:  1983-08       Impact factor: 9.910

View more
  23 in total

1.  Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry.

Authors:  G B Frisoni; C Testa; A Zorzan; F Sabattoli; A Beltramello; H Soininen; M P Laakso
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

Review 2.  FDG-PET Contributions to the Pathophysiology of Memory Impairment.

Authors:  Shailendra Segobin; Renaud La Joie; Ludivine Ritz; Hélène Beaunieux; Béatrice Desgranges; Gaël Chételat; Anne Lise Pitel; Francis Eustache
Journal:  Neuropsychol Rev       Date:  2015-08-30       Impact factor: 7.444

3.  A non-parametric approach for co-analysis of multi-modal brain imaging data: application to Alzheimer's disease.

Authors:  Satoru Hayasaka; An-Tao Du; Audrey Duarte; John Kornak; Geon-Ho Jahng; Michael W Weiner; Norbert Schuff
Journal:  Neuroimage       Date:  2006-01-10       Impact factor: 6.556

4.  Disruption of limbic white matter pathways in mild cognitive impairment and Alzheimer's disease: a DTI/FDG-PET study.

Authors:  Andrea C Bozoki; Igor O Korolev; Nathan C Davis; Lori A Hoisington; Kevin L Berger
Journal:  Hum Brain Mapp       Date:  2011-06-14       Impact factor: 5.038

5.  The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease.

Authors:  Sofie M Adriaanse; Koene R A van Dijk; Rik Ossenkoppele; Martin Reuter; Nelleke Tolboom; Marissa D Zwan; Maqsood Yaqub; Ronald Boellaard; Albert D Windhorst; Wiesje M van der Flier; Philip Scheltens; Adriaan A Lammertsma; Frederik Barkhof; Bart N M van Berckel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-11       Impact factor: 9.236

6.  Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Authors:  Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

Review 7.  Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2011-02       Impact factor: 3.911

8.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

Authors:  Nathan A Johnson; Geon-Ho Jahng; Michael W Weiner; Bruce L Miller; Helena C Chui; William J Jagust; Maria L Gorno-Tempini; Norbert Schuff
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

9.  Selective changes of resting-state networks in individuals at risk for Alzheimer's disease.

Authors:  Christian Sorg; Valentin Riedl; Mark Mühlau; Vince D Calhoun; Tom Eichele; Leonhard Läer; Alexander Drzezga; Hans Förstl; Alexander Kurz; Claus Zimmer; Afra M Wohlschläger
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

10.  Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease.

Authors:  Claudia Plant; Stefan J Teipel; Annahita Oswald; Christian Böhm; Thomas Meindl; Janaina Mourao-Miranda; Arun W Bokde; Harald Hampel; Michael Ewers
Journal:  Neuroimage       Date:  2009-12-02       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.